SanReno Therapeutics
Beijing
About SanReno Therapeutics
SanReno Therapeutics develop, manufacture and commercialize kidney disease therapies in the People’s Republic of China, Hong Kong, Macau, Taiwan and Singapore (the “Territory”). SanReno Therapeutics formed with JV of Chinook Therapeutics and Frazier Healthcare Partners and Pivotal bioVenture Partners China.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $40.0M
- Funding stage: M&A
- Last round: Undisclosed (Nov 2021)
- Website: sanreno.com
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/sanreno-therapeutics-124205 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.